MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism dementia complex(PDC)"

  • MDS Virtual Congress 2021

    Early-onset Dementia with Lewy Bodies and Parkinson’s Disease Dementia: A Population-based Study (2010-2015).

    E. Camerucci, C. Stang, M. Hajeb, P. Turcano, A. Mullan, D. Jones, J. Graff-Radford, O. Ross, J. Bower, B. Boeve, R. Savica (Rochester, USA)

    Objective: To examine the incidence, clinical features, and survival of early-onset Dementia with Lewy Bodies and Parkinson’s Disease Dementia (DLB/PDD) (≤55 years of age) in…
  • MDS Virtual Congress 2020

    Quantitative method for designing appropriate longitudinal follow-up frequency with application to Parkinson’s disease cognition research

    L. Suttner, S. Xie (Philadelphia, PA, USA)

    Objective: To develop a quantitative method for designing appropriate longitudinal follow-up frequency. We demonstrate how to use this new method using a progression study of…
  • MDS Virtual Congress 2020

    Prevalence of Neuropsychiatric Symptoms in the Prodromal Stages of Dementia with Lewy Bodies and Parkinson’s Disease Dementia

    K. Wyman-Chick, L. Erickson, D. Weintraub, M. Rosenbloom, T. Barclay, M. Barrett (St Paul, MN, USA)

    Objective: Investigate neuropsychiatric features of prodromal stage dementia among individuals diagnosed with Lewy body disease. Background: There has been minimal investigation into the prodromal features…
  • MDS Virtual Congress 2020

    White Matter Changes and Early Cognitive Impairment in Parkinson’s Disease

    T. Belal, S. Elgamal (Mansoura, Egypt)

    Objective: Studying white matter changes in Parkinson's disease patients using diffusion tensor imaging; and its relation to cognition and motor symptoms impairment. Background: Cognitive dysfunction…
  • MDS Virtual Congress 2020

    Anxiety disorders are associated with verbal memory impairment in Parkinson’s disease

    N. Dissanayaka, E. Forbes, J. Yang, J. O'Sullivan, D. Copland, K. McMahon, L. Mitchell, G. Byrne (Brisbane, Australia)

    Objective: The present study aimed to investigate the association between anxiety disorders and memory impairment in Parkinson’s disease.The present study aimed to investigate the association…
  • MDS Virtual Congress 2020

    Clock Drawing Test does not Differentiate Alzheimer’s Disease from Parkinson’s Disease Dementia

    S. Tezcan Aydemir, M. Kuzu Kumcu, C. Akbostancı (Ankara, Turkey)

    Objective: Our focus was on comparing the performance of CDT and MMSE in Parkinson’s Disease Dementia (PDD) and Alzheimer’s Disease (AD) patients. Background: The mini…
  • MDS Virtual Congress 2020

    Clinical characteristics of pain in Parkinson’s disease dementia

    B. Ciopleias, S. Diaconu, R. Chiujdea, C. Falup-Pecurariu (Braşov, Romania)

    Objective: The aim of this study was the assess the prevalence of pain in Parkinson’s disease dementia, its clinical characteristics, and correlations with motor part…
  • MDS Virtual Congress 2020

    When and how to stop subthalamic deep brain stimulation in late-stage Parkinson’s disease

    M. Fabbri, M. Zibetti, m. Rizzone, G. Giannini, L. Borellini, A. Stefani, F. Bove, A. Bruno, G. Calandra-buonaura, N. Modugno, C. Piano, A. Peppe, G. Ardolino, A. Romagnolo, C. Artusi, P. Berchialla, E. Montanaro, P. Cortelli, L. Romito, R. Eleopra, B. Minafra, C. Pacchetti, L. Lopiano (Bologna, Italy)

    Objective: We sought to investigate the percentage of “poor stimulation responders” among late-stage Parkinson's disease (LSPD) patients for elaborating an algorithm to decide whether and…
  • 2019 International Congress

    The effect of coexistent neurodegenerative disorders on the clinical features of idiopathic normal pressure hydrocephalus

    A. Hattori, T. Tsunemi, N. Hattori (Bunkyo-Ku, Japan)

    Objective: To determine the prevalence of neurodegenerative disorders in idiopathic normal pressure hydrocephalus (iNPH) and their effects on the clinical features of iNPH. Background: To…
  • 2019 International Congress

    Biomarkers of the Level of Cognitive Impairment (CI) in patients with Parkinson’s Disease (PD): MRS study

    I. Karaban', N. Karasevich, Z. Rozhkova (Kyiv, Ukraine)

    Objective: The concentrations of NAA, Cr, mIns, and Glx are identified as putative neurochemical markers of CI in patients with PD. Background: On the basis…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 7
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley